To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CPSF6TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
420 supporting clones for gene CPSF6 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
TI_1948086319   .a 1 to 953 128 to 1089   tiling clone, fully sequenced,   962/1089
(88 %)
29 diff
(97.4 %id)
TI_1948086487   .a 1 to 969 127 to 1090   tiling clone, fully sequenced,   964/1090
(88 %)
24 diff
(97.8 %id)
TI_1948086665   .a 1 to 959 130 to 1081   tiling clone, fully sequenced,   952/1081
(88 %)
13 diff
(98.8 %id)
TI_1948086837   .a 1 to 922 124 to 1061   tiling clone, fully sequenced,   938/1061
(88 %)
24 diff
(97.8 %id)
CX786414 human embryonic stem cells .a 884 to 1583 1 to 700   tiling clone,   700/700
(100 %)
0 diff
(100 %id)
TI_1948086838   .a 892 to 1769 1001 to 129   fully sequenced,   873/1001
(87 %)
17 diff
(98.4 %id)
TI_1948086320   .a 923 to 1769 962 to 125   tiling clone, fully sequenced,   838/962
(87 %)
15 diff
(98.5 %id)
TI_1948086666   .a 929 to 1769 960 to 128   fully sequenced,   833/960
(86 %)
4 diff
(99.6 %id)
TI_1948086488   .a 939 to 1769 942 to 128   fully sequenced,   815/942
(86 %)
9 diff
(99.1 %id)
CD643926 Embryonic Stem cells .a 1638 to 2401 1 to 761       761/856
(88 %)
14 diff
(98.4 %id)
CN280370 embryonic stem cells, cell lines H1, H7, andH9 .a 1707 to 2453 1 to 746   tiling clone,   746/746
(100 %)
2 diff
(99.8 %id)
CN280369 embryonic stem cells, DMSO-treated H9 cellline .a 2167 to 2453 1 to 286   tiling clone,   286/286
(100 %)
1 diff
(99.7 %id)
BC000714 Kidney, renal cell adenocarcinoma .b 1 to 2229 1 to 2229 exact tiling clone, available from MGC, AAA   2229/2229
(100 %)
0 diff
(100 %id)
BU161014 melanotic melanoma, skin .b 13 to 835 1 to 836       836/905
(92 %)
20 diff
(97.8 %id)
BQ066135 lymph, lymphoma, cell line .b 92 to 909 120 to 945       823/986
(83 %)
25 diff
(97.5 %id)
BM742862 Ascites, stomach .b 134 to 754 1 to 621       621/621
(100 %)
0 diff
(100 %id)
AL557975 T cells from T cell leukemia .b 170 to 1081 1 to 904       904/1095
(82 %)
16 diff
(98.6 %id)
DR761900 embryonic stem .b 271 to 1076 1 to 807       807/807
(100 %)
1 diff
(99.9 %id)
CX753634 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 303 to 1078 1 to 764     Submitted on the opposite strand 764/844
(90 %)
21 diff
(97.6 %id)
DR762073 embryonic stem .b 311 to 1040 1 to 731       731/731
(100 %)
2 diff
(99.8 %id)
BF154604 breast_normal .b 386 to 811 431 to 5       427/433
(98 %)
3 diff
(99.4 %id)
BU542160 carcinoma, cell line, Prostate .b 425 to 1284 1 to 873       873/882
(98 %)
24 diff
(97.3 %id)
CN354305 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 488 to 982 1 to 495       495/495
(100 %)
1 diff
(99.8 %id)
BE542913 cervix .b 530 to 1201 1 to 679       679/999
(67 %)
48 diff
(95.2 %id)
BM459503 leiomyosarcoma, uterus .b 609 to 1391 1 to 783       783/905
(86 %)
14 diff
(98.5 %id)
BM905514 embryonal carcinoma, cell line, testis .b 642 to 1237 17 to 613       597/1013
(58 %)
19 diff
(98.2 %id)
BP263434 small intestine .b 730 to 1310 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
AL579902 T cells from T cell leukemia .b 1094 to 2200 1089 to 1       1089/1118
(97 %)
41 diff
(96.4 %id)
NM_007007.2   .c 1 to 6614 2 to 6615 exact RefSeq, AAA   6615/6615
(100 %)
0 diff
(100 %id)
DA365448 subthalamic nucleus .c 1 to 572 2 to 574   tiling clone, capped   573/573
(100 %)
2 diff
(99.7 %id)
DA617210   .c 7 to 577 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
DA846907 placenta .c 7 to 579 2 to 575   capped   574/575
(99 %)
4 diff
(99.4 %id)
DB019524 testis .c 12 to 719 2 to 709   capped   708/708
(100 %)
2 diff
(99.8 %id)
DA580456   .c 16 to 571 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BI458693 testis .c 30 to 603 1 to 574       574/574
(100 %)
7 diff
(98.8 %id)
DA362735 subthalamic nucleus .c 32 to 580 2 to 550   capped   549/549
(100 %)
4 diff
(99.3 %id)
BG723278 testis .c 32 to 567 6 to 541       536/541
(99 %)
6 diff
(98.9 %id)
DA888099   .c 32 to 590 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
BP376858 uterus .c 32 to 584 1 to 553       553/553
(100 %)
2 diff
(99.7 %id)
DA352263 substantia nigra .c 33 to 609 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA466283   .c 33 to 612 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA576812   .c 33 to 611 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA659427   .c 33 to 605 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA670953   .c 33 to 622 2 to 591   capped   590/590
(100 %)
2 diff
(99.7 %id)
DA817364   .c 33 to 608 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
DB206582 trachea .c 33 to 613 2 to 583   capped   582/582
(100 %)
3 diff
(99.5 %id)
DB451757 testis .c 34 to 527 1 to 494       494/494
(100 %)
2 diff
(99.6 %id)
DB461153 testis .c 34 to 518 1 to 486       486/486
(100 %)
21 diff
(95.7 %id)
DA666933   .c 34 to 587 2 to 556   capped   555/555
(100 %)
5 diff
(99.1 %id)
AK223568 heart .c 35 to 2147 1 to 2113 exact     2113/2113
(100 %)
0 diff
(100 %id)
DA473393   .c 35 to 573 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
BP225978   .c 35 to 615 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DB452334 testis .c 35 to 511 1 to 477       477/479
(99 %)
1 diff
(99.8 %id)
BP282453 bone marrow .c 35 to 615 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA907038   .c 35 to 596 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BP353909   .c 35 to 615 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DA013109 adrenal gland .c 36 to 593 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA017695 adrenal gland .c 36 to 620 2 to 589   capped   588/588
(100 %)
4 diff
(99.4 %id)
DA032731   .c 36 to 615 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA088248 cerebellum .c 36 to 580 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA249239 brain .c 36 to 629 2 to 595   capped   594/594
(100 %)
1 diff
(99.9 %id)
DA336492 hippocampus .c 36 to 627 2 to 593   capped   592/592
(100 %)
2 diff
(99.7 %id)
DA351144 substantia nigra .c 36 to 622 2 to 588   capped   587/587
(100 %)
2 diff
(99.7 %id)
DA351495 substantia nigra .c 36 to 621 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA487499 brain .c 36 to 590 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA590138 lung .c 36 to 582 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA904270   .c 36 to 617 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
DA943823 Spleen .c 36 to 609 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DB032507 testis .c 36 to 578 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB113823 thymus .c 36 to 613 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
BG719491 testis .c 39 to 777 1 to 742       742/816
(90 %)
13 diff
(98.5 %id)
CN354304 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 42 to 723 1 to 682       682/682
(100 %)
3 diff
(99.6 %id)
BI850913 embryonal carcinoma, cell line, testis .c 42 to 699 1 to 662       662/662
(100 %)
9 diff
(98.7 %id)
AU130031   .c 42 to 891 2 to 851   capped   850/850
(100 %)
13 diff
(98.5 %id)
DA816819   .c 45 to 624 2 to 581   capped   580/580
(100 %)
3 diff
(99.5 %id)
TI_57235926   .c 52 to 803 95 to 853       759/903
(84 %)
28 diff
(96.9 %id)
CR623508 fetal liver .c 54 to 2167 1 to 2114 exact tiling clone,   2114/2114
(100 %)
0 diff
(100 %id)
AL532223 brain, fetal liver, Liver, neuroblastoma cells .c 54 to 915 1 to 862       862/862
(100 %)
0 diff
(100 %id)
AL561459 B cells from Burkitt lymphoma .c 55 to 1040 1 to 985       985/988
(99 %)
3 diff
(99.7 %id)
BQ686757 ductal carcinoma, cell line, Pancreas .c 59 to 920 1 to 871       871/916
(95 %)
23 diff
(97.5 %id)
AL710755 human skeletal muscle .c 62 to 703 1 to 641       641/641
(100 %)
5 diff
(99.3 %id)
BP264637 umbilical vein .c 62 to 637 1 to 576       576/576
(100 %)
4 diff
(99.4 %id)
BP271615   .c 62 to 677 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
AU280247   .c 62 to 625 1 to 564       564/564
(100 %)
0 diff
(100 %id)
DB124149 thymus .c 62 to 631 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA012553 adrenal gland .c 63 to 629 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA504358 brain .c 63 to 619 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA522863 brain .c 63 to 644 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA576305   .c 63 to 624 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA581122 lung .c 63 to 540 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
DA953653 Spleen .c 63 to 635 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA960385 Spleen .c 63 to 619 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB026308 testis .c 63 to 617 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB054876 testis .c 63 to 626 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB116325 thymus .c 63 to 556 2 to 495   capped   494/494
(100 %)
0 diff
(100 %id)
BE301880 Kidney, renal cell adenocarcinoma .c 64 to 655 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
BM788755 stomach .c 66 to 712 1 to 647       647/647
(100 %)
0 diff
(100 %id)
BP284581 bone marrow .c 68 to 654 1 to 587       587/587
(100 %)
0 diff
(100 %id)
DA348468 substantia nigra .c 69 to 656 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA956661 Spleen .c 69 to 619 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB084261 testis .c 69 to 651 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
DB145617 thymus .c 69 to 614 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DB246501 uterus, tumor tissue .c 69 to 633 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
AL711152 human skeletal muscle .c 74 to 658 1 to 585       585/585
(100 %)
3 diff
(99.5 %id)
BM470023 melanotic melanoma, skin .c 75 to 777 1 to 711       711/1053
(67 %)
21 diff
(98.1 %id)
CX752906 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 75 to 808 1 to 724     Submitted on the opposite strand 724/775
(93 %)
15 diff
(98.1 %id)
BQ069613 brain, neuroblastoma, cell line .c 76 to 944 1 to 888       887/1109
(79 %)
39 diff
(96.5 %id)
DB205235 trachea .c 76 to 661 2 to 587   capped   586/586
(100 %)
2 diff
(99.7 %id)
BM461694 leiomyosarcoma, uterus .c 79 to 876 1 to 806       806/915
(88 %)
16 diff
(98.3 %id)
BI822149 pooled brain, lung, testis .c 80 to 995 1 to 915       915/940
(97 %)
19 diff
(98.0 %id)
TI_57201765   .c 80 to 995 37 to 951       915/976
(93 %)
25 diff
(97.5 %id)
BM787700 stomach .c 80 to 699 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
TI_44459673   .c 82 to 779 85 to 782       698/782
(89 %)
7 diff
(99.2 %id)
X67337 brain .c 83 to 3500 8 to 3426 D9N tiling clone,   3419/3426
(99 %)
12 diff
(99.7 %id)
CN354293 embryonic stem cells, DMSO-treated H9 cellline .c 87 to 725 1 to 641       641/652
(98 %)
4 diff
(99.4 %id)
BI518765 leukocyte .c 88 to 779 1 to 692       692/692
(100 %)
1 diff
(99.9 %id)
BX490871   .c 89 to 662 1 to 574       574/574
(100 %)
5 diff
(99.2 %id)
CN354295 embryonic stem cells, DMSO-treated H9 cellline .c 92 to 447 1 to 356       356/356
(100 %)
0 diff
(100 %id)
CR601123 HeLa cells Cot 25-normalized .c 93 to 1893 1 to 1801 exact     1801/1801
(100 %)
0 diff
(100 %id)
AL556926 placenta .c 93 to 1031 1 to 928   fully sequenced,   928/928
(100 %)
1 diff
(99.9 %id)
CN354299 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 95 to 816 1 to 722       722/722
(100 %)
0 diff
(100 %id)
DA959132 Spleen .c 100 to 657 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB176444 kidney, tumor tissue .c 100 to 659 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
AK292024 Spleen .c 102 to 2042 1 to 1941 exact     1941/1941
(100 %)
2 diff
(99.9 %id)
BX393428 Neuroblastoma Cot 10-normalized .c 102 to 957 1 to 855       855/865
(98 %)
2 diff
(99.8 %id)
BU175246 embryonal carcinoma, cell line, testis .c 102 to 946 1 to 857       857/930
(92 %)
25 diff
(97.4 %id)
BE780968 eye, retinoblastoma .c 104 to 800 1 to 695       695/903
(76 %)
7 diff
(99.3 %id)
BM477830 leiomyosarcoma, uterus .c 105 to 990 13 to 911       899/1092
(82 %)
27 diff
(97.6 %id)
BU844439 ovary, teratocarcinoma, cell line .c 106 to 983 1 to 891       891/893
(99 %)
16 diff
(98.3 %id)
CV025780 mixed .c 110 to 723 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BI820300 pooled brain, lung, testis .c 114 to 905 1 to 787       787/789
(99 %)
21 diff
(97.4 %id)
TI_57199479   .c 114 to 905 37 to 823       787/825
(95 %)
27 diff
(96.8 %id)
BE780205 eye, retinoblastoma .c 120 to 807 1 to 686   AAA   686/993
(69 %)
16 diff
(98.4 %id)
BE255983 eye, retinoblastoma .c 124 to 773 1 to 645       647/647
(100 %)
8 diff
(98.8 %id)
AL544660 placenta, Placenta Cot 25-normalized .c 134 to 996 1 to 864       864/864
(100 %)
4 diff
(99.6 %id)
CN354307 embryonic stem cells, cell lines H1, H7, andH9 .c 141 to 846 1 to 706       706/706
(100 %)
2 diff
(99.8 %id)
BM697532 eye, fetal eyes .c 167 to 649 14 to 495       482/495
(97 %)
8 diff
(98.4 %id)
TI_154177179   .c 168 to 710 81 to 624       544/544
(100 %)
2 diff
(99.7 %id)
DR156741 human embryonic stem cells differentiated toan early endodermal cell type .c 211 to 1047 1 to 837       837/837
(100 %)
0 diff
(100 %id)
EB387314 eye, optic nerve .c 220 to 1061 1 to 841       841/841
(100 %)
4 diff
(99.6 %id)
BI087288 cervix .c 249 to 1047 1 to 801       801/824
(97 %)
21 diff
(97.5 %id)
AU125770   .c 267 to 928 2 to 663   capped   662/665
(99 %)
2 diff
(99.7 %id)
CN354306 embryonic stem cells, DMSO-treated H9 cellline .c 284 to 993 1 to 710       710/710
(100 %)
2 diff
(99.8 %id)
CF132170 Chondrosarcoma Lung Metastasis cell lines, lung .c 290 to 1018 1 to 726       726/726
(100 %)
6 diff
(99.2 %id)
TI_159677910   .c 290 to 1205 48 to 941       894/1075
(83 %)
27 diff
(97.5 %id)
CF141943 CNCAP(3)T-225 cell line, Prostate .c 301 to 785 7 to 491       485/491
(98 %)
0 diff
(100 %id)
TI_154172817   .c 301 to 899 79 to 682       604/604
(100 %)
10 diff
(98.4 %id)
AA354466   .c 341 to 648 1 to 308       308/308
(100 %)
0 diff
(100 %id)
BE266196 lung, small cell carcinoma .c 399 to 1025 1 to 626       626/709
(88 %)
8 diff
(98.9 %id)
CN354296 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 416 to 1059 1 to 643       643/643
(100 %)
2 diff
(99.7 %id)
BP355388   .c 425 to 1005 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BE797013 lung, small cell carcinoma .c 483 to 1309 1 to 807       807/962
(83 %)
33 diff
(96.6 %id)
AW581681 pnet .c 489 to 577 91 to 1       91/109
(83 %)
4 diff
(96.4 %id)
BG750343 eye, normal pigmented retinal epithelium .c 571 to 1301 1 to 727       727/727
(100 %)
9 diff
(98.8 %id)
TI_57198296   .c 578 to 1364 73 to 862       790/867
(91 %)
20 diff
(97.7 %id)
AW411223 muscle, rhabdomyosarcoma .c 616 to 1291 10 to 685       676/685
(98 %)
0 diff
(100 %id)
BG676334 skin, squamous cell carcinoma .c 624 to 1518 1 to 893       893/895
(99 %)
23 diff
(97.5 %id)
BP368706 thymus .c 639 to 1219 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BM550767 melanotic melanoma, skin .c 717 to 1704 1 to 989       986/1087
(90 %)
10 diff
(99.1 %id)
BX410154 fetal liver, Liver .c 797 to 1694 1 to 896       896/896
(100 %)
5 diff
(99.5 %id)
CD623549   .c 815 to 1604 1 to 794       794/805
(98 %)
11 diff
(98.7 %id)
BM743362 Ascites, stomach .c 816 to 1445 1 to 630       630/630
(100 %)
0 diff
(100 %id)
BM766794 Ascites, stomach .c 816 to 1415 1 to 600       600/600
(100 %)
0 diff
(100 %id)
BM748250 Ascites, stomach .c 816 to 1423 1 to 608       608/608
(100 %)
5 diff
(99.2 %id)
BM758253 Ascites, stomach .c 816 to 1390 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BM757710 Ascites, stomach .c 816 to 1445 1 to 630       630/630
(100 %)
0 diff
(100 %id)
BM758741 Ascites, stomach .c 816 to 1507 1 to 691       691/691
(100 %)
1 diff
(99.9 %id)
BM757590 Ascites, stomach .c 816 to 1373 1 to 558       558/558
(100 %)
0 diff
(100 %id)
BM758309 Ascites, stomach .c 816 to 1370 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BM758577 Ascites, stomach .c 816 to 1483 1 to 668       668/668
(100 %)
0 diff
(100 %id)
BM772546 Ascites, stomach .c 816 to 1481 1 to 666       666/666
(100 %)
2 diff
(99.7 %id)
FN072246 breast carcinoma .c 874 to 960 1 to 84       84/85
(98 %)
4 diff
(95.3 %id)
CD623548   .c 882 to 1607 742 to 19       724/742
(97 %)
3 diff
(99.6 %id)
BY997192   .c 933 to 1574 29 to 669       641/669
(95 %)
6 diff
(99.2 %id)
BM748651 Ascites, stomach .c 936 to 1048 1 to 113       113/113
(100 %)
0 diff
(100 %id)
CX759767 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 958 to 1754 1 to 784     Submitted on the opposite strand 784/852
(92 %)
21 diff
(97.6 %id)
BX508178   .c 977 to 1664 1 to 688       688/688
(100 %)
0 diff
(100 %id)
AL556891 placenta .c 1001 to 1893 879 to 1   fully sequenced,   879/879
(100 %)
3 diff
(99.7 %id)
BX094475 melanocyte .c 1071 to 1725 1 to 654       654/654
(100 %)
1 diff
(99.9 %id)
N28996 melanocyte .c 1071 to 1531 1 to 468       468/484
(96 %)
8 diff
(98.4 %id)
AW379794 head_neck .c 1072 to 1387 375 to 690   AAA   316/748
(42 %)
11 diff
(98.6 %id)
BM790086 stomach .c 1094 to 1353 1 to 260       260/260
(100 %)
0 diff
(100 %id)
AL582659 B cells from Burkitt lymphoma .c 1133 to 2153 1027 to 10       1018/1027
(99 %)
4 diff
(99.7 %id)
BM561323 duodenal adenocarcinoma, cell line, small intestine .c 1145 to 2154 1 to 1017       1017/1020
(99 %)
21 diff
(98.0 %id)
BI254332 cervical carcinoma cell line, cervix .c 1152 to 2067 1 to 915       915/917
(99 %)
31 diff
(96.7 %id)
AA341622 Kidney .c 1196 to 1476 1 to 281       281/281
(100 %)
0 diff
(100 %id)
AV708633 adrenal gland .c 1217 to 1619 1 to 403       403/403
(100 %)
0 diff
(100 %id)
AV726471 hypothalamus .c 1217 to 1996 1 to 783       783/783
(100 %)
23 diff
(97.1 %id)
AV726440 hypothalamus .c 1217 to 1619 1 to 403       403/403
(100 %)
0 diff
(100 %id)
BU623328 cell lines, Chondrosarcoma .c 1223 to 1927 723 to 19   AAA   705/705
(100 %)
1 diff
(99.9 %id)
TI_149297185   .c 1245 to 2196 1061 to 115   AAA   947/950
(99 %)
25 diff
(97.4 %id)
AL564321 brain, fetal liver, Liver, neuroblastoma cells .c 1251 to 2167 915 to 1       915/915
(100 %)
3 diff
(99.7 %id)
AL570817 placenta, Placenta Cot 25-normalized .c 1254 to 2153 911 to 12       900/911
(98 %)
2 diff
(99.8 %id)
EC443355 Prostate .c 1270 to 1368 10 to 109       100/109
(91 %)
9 diff
(91.8 %id)
AA043838 uterus .c 1280 to 1478 1 to 199       199/204
(97 %)
2 diff
(99.1 %id)
TI_159721029   .c 1308 to 2196 980 to 95   AAA   886/1035
(85 %)
8 diff
(99.3 %id)
FN159001 breast carcinoma .c 1351 to 1426 1 to 78       78/87
(89 %)
2 diff
(97.8 %id)
AW950975   .c 1411 to 1927 1 to 517   AAA   517/517
(100 %)
0 diff
(100 %id)
TI_149302878   .c 1425 to 2205 858 to 80   AAA   776/946
(82 %)
9 diff
(99.1 %id)
CA308366 Alveolar Macrophage, lung .c 1433 to 2196 782 to 19   AAA   764/764
(100 %)
1 diff
(99.9 %id)
CB852974 Human Lung Epithelial cells, lung .c 1445 to 2196 768 to 19   AAA   750/750
(100 %)
2 diff
(99.8 %id)
AA442135   .c 1463 to 1770 98 to 405   fully sequenced,   308/405
(76 %)
6 diff
(98.6 %id)
BP240930 Liver .c 1473 to 2053 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP241233 Liver .c 1473 to 2051 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
AW819913 stomach .c 1479 to 1949 471 to 1       471/471
(100 %)
0 diff
(100 %id)
AU127462   .c 1479 to 2167 2 to 689   capped   688/691
(99 %)
11 diff
(98.5 %id)
AI761598 pooled .c 1481 to 2196 720 to 6       715/720
(99 %)
3 diff
(99.6 %id)
BQ009963 Chondrosarcoma, Left Pubic Bone .c 1492 to 2196 723 to 19   AAA   705/705
(100 %)
0 diff
(100 %id)
C03053 heart .c 1506 to 1727 1 to 222       222/222
(100 %)
0 diff
(100 %id)
BI093224 cervix .c 1523 to 2198 1 to 677       677/677
(100 %)
6 diff
(99.2 %id)
TI_149272388   .c 1527 to 2195 762 to 94   AAA   669/1014
(65 %)
0 diff
(100 %id)
BU675035 lung, Primary Lung Epithelial Cells .c 1527 to 2195 687 to 19   AAA   669/681
(98 %)
0 diff
(100 %id)
AA682629 liver and spleen .c 1529 to 1925 1 to 397     Submitted on the opposite strand 397/397
(100 %)
0 diff
(100 %id)
CA453867 mixed (pool of 40 RNAs) .c 1559 to 2342 1 to 790       790/791
(99 %)
11 diff
(98.7 %id)
T98089 liver and spleen .c 1565 to 1873 1 to 316       316/334
(94 %)
14 diff
(95.9 %id)
BQ425262 melanotic melanoma, skin .c 1578 to 2380 1 to 803   AAA   803/803
(100 %)
2 diff
(99.8 %id)
BM716550 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1580 to 1799 1 to 220   fully sequenced,   220/220
(100 %)
0 diff
(100 %id)
TI_151776817   .c 1580 to 2162 74 to 657       584/1259
(46 %)
12 diff
(99.1 %id)
AA027333 heart .c 1581 to 1768 1 to 187   fully sequenced,   187/187
(100 %)
0 diff
(100 %id)
AA902347 carcinoid, lung .c 1595 to 2195 617 to 16   AAA   602/602
(100 %)
4 diff
(99.4 %id)
TI_149287636   .c 1604 to 2379 834 to 61   AAA   774/1134
(68 %)
11 diff
(99.1 %id)
TI_157602232   .c 1608 to 2196 715 to 130   AAA   586/867
(67 %)
13 diff
(98.6 %id)
CB850605 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1611 to 2196 604 to 19   AAA   586/586
(100 %)
1 diff
(99.9 %id)
T96735 liver and spleen .c 1621 to 1967 1 to 359   fully sequenced,   359/359
(100 %)
22 diff
(93.9 %id)
BM726399 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1631 to 2194 1 to 564   AAA   564/564
(100 %)
0 diff
(100 %id)
AI375424 brain, glioblastoma (pooled) .c 1648 to 2196 575 to 5       571/575
(99 %)
0 diff
(100 %id)
DB335562 testis .c 1658 to 2195 545 to 1       545/545
(100 %)
18 diff
(96.7 %id)
AA627879 breast .c 1661 to 1715 55 to 1       55/55
(100 %)
2 diff
(96.4 %id)
BG119910 adenocarcinoma, cell line, Liver .c 1663 to 2196 1 to 533       533/594
(89 %)
7 diff
(98.9 %id)
AU149367   .c 1675 to 2195 521 to 1       521/521
(100 %)
10 diff
(98.1 %id)
AA025881 heart .c 1676 to 2196 535 to 11   AAA   525/530
(99 %)
5 diff
(99.1 %id)
AI740944 pooled .c 1677 to 2195 532 to 14   AAA   519/519
(100 %)
1 diff
(99.9 %id)
AA777279 liver and spleen .c 1688 to 2196 509 to 1       509/509
(100 %)
0 diff
(100 %id)
BP392172 pancreatic islet .c 1696 to 2196 1 to 501     Submitted on the opposite strand 501/501
(100 %)
2 diff
(99.7 %id)
BM989562 lung, Metastatic Chondrosarcoma .c 1711 to 2382 688 to 19   AAA   670/670
(100 %)
2 diff
(99.8 %id)
EC457999 Prostate .c 1712 to 1807 9 to 106       98/106
(92 %)
7 diff
(93.4 %id)
AW009889 colon .c 1720 to 2196 483 to 7       477/483
(98 %)
0 diff
(100 %id)
AI051846   .c 1721 to 2195 475 to 1       475/475
(100 %)
0 diff
(100 %id)
AI138462 placenta .c 1723 to 2195 477 to 5       473/477
(99 %)
0 diff
(100 %id)
AA043839 uterus .c 1724 to 2205 494 to 12   AAA   483/483
(100 %)
1 diff
(99.8 %id)
BG179401 adenocarcinoma, cell line, Prostate .c 1724 to 2242 1 to 531       529/715
(73 %)
28 diff
(96.1 %id)
BM972926 lung .c 1725 to 2379 670 to 16   AAA   655/655
(100 %)
0 diff
(100 %id)
FN115459 breast carcinoma .c 1730 to 1833 104 to 1     Submitted on the opposite strand 104/104
(100 %)
0 diff
(100 %id)
AI088478 uterus .c 1731 to 2196 470 to 5       466/470
(99 %)
0 diff
(100 %id)
BI832884 pooled pancreas and spleen .c 1734 to 2196 1 to 463   AAA   463/550
(84 %)
1 diff
(99.9 %id)
TI_57162347   .c 1734 to 2196 36 to 498   AAA   463/585
(79 %)
7 diff
(98.9 %id)
AA027334 heart .c 1737 to 2196 474 to 8   fully sequenced,   467/474
(98 %)
2 diff
(99.6 %id)
BQ012530 placenta .c 1738 to 2196 477 to 19   AAA   459/459
(100 %)
0 diff
(100 %id)
BU738597 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1738 to 2383 664 to 19   fully sequenced, AAA   646/646
(100 %)
1 diff
(99.9 %id)
BQ015661 placenta .c 1745 to 2196 469 to 18   AAA   452/452
(100 %)
1 diff
(99.8 %id)
AI147244 uterus .c 1756 to 2196 447 to 7       441/447
(98 %)
0 diff
(100 %id)
BE206539 Kidney, renal cell adenocarcinoma .c 1756 to 2196 452 to 12   AAA   441/441
(100 %)
3 diff
(99.4 %id)
DB568447 hypothalamus .c 1763 to 2196 26 to 460     Submitted on the opposite strand 435/460
(94 %)
6 diff
(98.7 %id)
AA442136   .c 1767 to 2196 436 to 7   fully sequenced,   430/436
(98 %)
0 diff
(100 %id)
AW473556 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1767 to 2197 432 to 2       431/442
(97 %)
0 diff
(100 %id)
CF529408 placenta .c 1767 to 2196 448 to 19   AAA   430/440
(97 %)
1 diff
(99.8 %id)
BG181913   .c 1773 to 2196 22 to 447   AAA   426/447
(95 %)
6 diff
(98.7 %id)
N26253 melanocyte .c 1782 to 2196 418 to 5       414/418
(99 %)
0 diff
(100 %id)
DB510462 testis .c 1789 to 2196 1 to 406   AAA Submitted on the opposite strand 406/406
(100 %)
4 diff
(99.1 %id)
AI038826 senescent fibroblast .c 1796 to 2195 409 to 10       400/409
(97 %)
0 diff
(100 %id)
AI632372 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1800 to 2196 406 to 10       397/406
(97 %)
0 diff
(100 %id)
BQ011544 placenta .c 1801 to 2195 413 to 19   AAA   395/395
(100 %)
0 diff
(100 %id)
AW629393 pooled .c 1804 to 2195 399 to 9       391/399
(97 %)
0 diff
(100 %id)
CF529411 placenta .c 1807 to 2196 408 to 19   AAA   390/390
(100 %)
0 diff
(100 %id)
AI753686 bone marrow stroma .c 1810 to 2199 427 to 38   AAA   390/390
(100 %)
1 diff
(99.8 %id)
N20600 melanocyte .c 1811 to 2196 387 to 1       387/395
(97 %)
2 diff
(99.5 %id)
AA678017 liver and spleen .c 1813 to 2195 383 to 1       383/383
(100 %)
0 diff
(100 %id)
AA825397 germinal center B cell .c 1820 to 2196 399 to 23   AAA   377/377
(100 %)
0 diff
(100 %id)
AA826053 germinal center B cell .c 1820 to 2199 401 to 22   AAA   380/380
(100 %)
0 diff
(100 %id)
AA908476 ovary, serous adenocarcinoma .c 1834 to 2195 372 to 11   AAA   362/362
(100 %)
0 diff
(100 %id)
FN175354 breast carcinoma .c 1845 to 1946 104 to 1     Submitted on the opposite strand 104/104
(100 %)
2 diff
(98.1 %id)
AA862878 Kidney .c 1845 to 2195 352 to 1       352/352
(100 %)
1 diff
(99.8 %id)
H89171 cochlea, ear .c 1854 to 2196 1 to 355   fully sequenced,   355/355
(100 %)
16 diff
(95.5 %id)
AA659364 metastatic prostate bone lesion .c 1865 to 2196 343 to 12   AAA   332/332
(100 %)
1 diff
(99.7 %id)
AA991283 breast .c 1870 to 2196 328 to 2       327/328
(99 %)
0 diff
(100 %id)
AA897155 pooled .c 1872 to 2196 328 to 4       325/328
(99 %)
0 diff
(100 %id)
AA884612 pooled .c 1872 to 2196 354 to 30   AAA   325/325
(100 %)
0 diff
(100 %id)
BM450754 eye, retinoblastoma .c 1873 to 2509 50 to 691   AAA   642/691
(92 %)
6 diff
(99.2 %id)
D11963 Liver .c 1897 to 2196 1 to 300       300/300
(100 %)
0 diff
(100 %id)
AI284422 Kidney .c 1904 to 2197 294 to 1       294/294
(100 %)
0 diff
(100 %id)
AU152079   .c 1907 to 2383 476 to 1       476/559
(85 %)
5 diff
(99.2 %id)
DB517248 testis .c 1918 to 2195 1 to 279     Submitted on the opposite strand 279/280
(99 %)
14 diff
(95.0 %id)
FN165084 breast carcinoma .c 1919 to 2044 1 to 125       125/125
(100 %)
3 diff
(97.6 %id)
AA749199 germinal center B cell .c 1937 to 2383 458 to 12   AAA   447/447
(100 %)
0 diff
(100 %id)
AI369473   .c 1937 to 2196 269 to 10       260/269
(96 %)
0 diff
(100 %id)
BU735730 eye, fetal eyes .c 1955 to 2194 258 to 19   AAA   240/240
(100 %)
0 diff
(100 %id)
T96624 liver and spleen .c 1957 to 2189 233 to 1   fully sequenced,   233/233
(100 %)
3 diff
(98.8 %id)
T98010 liver and spleen .c 1960 to 2196 243 to 6       238/252
(94 %)
0 diff
(100 %id)
BM562572 duodenal adenocarcinoma, cell line, small intestine .c 1977 to 2196 1 to 220   AAA   220/220
(100 %)
0 diff
(100 %id)
AA533418 normal prostatic epithelial cells, Prostate .c 1978 to 2196 236 to 18   AAA   219/226
(96 %)
1 diff
(99.6 %id)
H88941 cochlea, ear .c 1983 to 2168 187 to 1   fully sequenced,   187/187
(100 %)
0 diff
(100 %id)
AI222395 pooled .c 2043 to 2379 337 to 1       337/337
(100 %)
0 diff
(100 %id)
DB507911 testis .c 2050 to 2199 1 to 149     Submitted on the opposite strand 149/149
(100 %)
4 diff
(97.4 %id)
AA505419 breast .c 2092 to 2195 107 to 4       104/107
(97 %)
0 diff
(100 %id)
FN126718 breast carcinoma .c 2097 to 2196 1 to 101       101/103
(98 %)
2 diff
(98.1 %id)
DA119080 cerebellum .c 2148 to 2372 2 to 226   capped   225/225
(100 %)
0 diff
(100 %id)
DA238431 brain .c 2157 to 2758 2 to 605   capped   604/604
(100 %)
4 diff
(99.4 %id)
FN152186 breast carcinoma .c 2208 to 2314 1 to 107       107/107
(100 %)
0 diff
(100 %id)
DA241951 brain .c 2396 to 2975 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA991585 synovial membrane tissue from rheumatioidarthritis .c 2410 to 2947 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA111939 cerebellum .c 2429 to 3018 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
DB235329 trachea .c 2430 to 3021 2 to 593   tiling clone, capped   592/592
(100 %)
0 diff
(100 %id)
DA246958 brain .c 2573 to 3153 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BG502873 embryonal carcinoma, testis .c 2582 to 3348 1 to 770       770/789
(97 %)
20 diff
(97.5 %id)
AL699946 human skeletal muscle .c 2585 to 3275 1 to 689       689/689
(100 %)
5 diff
(99.3 %id)
FN119640 breast carcinoma .c 2607 to 2674 68 to 1     Submitted on the opposite strand 68/68
(100 %)
0 diff
(100 %id)
DA404183 thalamus .c 2667 to 3238 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
FN097002 breast carcinoma .c 2692 to 2792 99 to 1     Submitted on the opposite strand 99/99
(100 %)
3 diff
(97.0 %id)
TI_57188010   .c 2714 to 3382 51 to 719       669/670
(99 %)
6 diff
(99.2 %id)
BI859058 breast, mammary adenocarcinoma, cell line .c 2715 to 3382 1 to 668       668/669
(99 %)
5 diff
(99.3 %id)
DA249174 brain .c 2739 to 3335 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
CN354300 embryonic stem cells, DMSO-treated H9 cellline .c 2744 to 3377 1 to 635       635/635
(100 %)
7 diff
(98.9 %id)
DA105462 cerebellum .c 2824 to 3398 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA230481 brain .c 2918 to 3492 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
FN073939 breast carcinoma .c 2940 to 3046 1 to 102       102/103
(99 %)
5 diff
(95.2 %id)
CD657062 Embryonic Stem cells .c 2950 to 3709 8 to 757   tiling clone,   750/798
(93 %)
17 diff
(97.9 %id)
AL700063 human skeletal muscle .c 2968 to 3619 1 to 651       651/651
(100 %)
1 diff
(99.9 %id)
DA220068 brain .c 2973 to 3555 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DB152631 thymus .c 2986 to 3580 2 to 598   capped   597/597
(100 %)
3 diff
(99.5 %id)
AI637585 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 3078 to 3485 408 to 1       408/408
(100 %)
0 diff
(100 %id)
DA225518 brain .c 3108 to 3778 2 to 672   capped   671/671
(100 %)
0 diff
(100 %id)
BX491468   .c 3238 to 3890 1 to 652       652/652
(100 %)
6 diff
(99.1 %id)
AU118799 whole embryo, mainly head .c 3262 to 4056 2 to 799   capped   798/798
(100 %)
6 diff
(99.3 %id)
CD678559 eye, Trabecular meshwork .c 3275 to 3705 1 to 431   AAA   431/431
(100 %)
0 diff
(100 %id)
DB364328   .c 3365 to 3787 423 to 1       423/423
(100 %)
8 diff
(98.2 %id)
DB086970 testis .c 3407 to 3925 2 to 520   tiling clone, capped   519/519
(100 %)
0 diff
(100 %id)
AA580159 breast .c 3485 to 3787 303 to 1       303/303
(100 %)
0 diff
(100 %id)
DA790476 brain .c 3738 to 4292 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BE468218 carcinoid, lung .c 3746 to 4103 358 to 1       358/358
(100 %)
0 diff
(100 %id)
DA795800 brain .c 3772 to 4318 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
CN359645 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 3790 to 4411 1 to 621       621/630
(98 %)
2 diff
(99.7 %id)
CN359644 embryonic stem cells, cell lines H1, H7, andH9 .c 3805 to 4454 1 to 652   tiling clone,   652/652
(100 %)
4 diff
(99.4 %id)
DA732807   .c 3965 to 4783 2 to 832   capped   831/855
(97 %)
22 diff
(97.5 %id)
AK098338 uterus .c 4052 to 6611 1 to 2559   tiling clone, available from FLJ,   2559/2559
(100 %)
8 diff
(99.7 %id)
DA792772 brain .c 4104 to 4730 2 to 631   capped   630/630
(100 %)
5 diff
(99.3 %id)
AA910841 carcinoid, lung .c 4187 to 4387 1 to 201     Submitted on the opposite strand 201/201
(100 %)
0 diff
(100 %id)
AI299651 carcinoid, lung .c 4187 to 4611 1 to 425   tiling clone, Submitted on the opposite strand 425/425
(100 %)
0 diff
(100 %id)
FN128611 breast carcinoma .c 4192 to 4298 106 to 1     Submitted on the opposite strand 106/106
(100 %)
7 diff
(93.4 %id)
DA130101 alzheimer cortex .c 4255 to 4888 2 to 636   capped   635/635
(100 %)
2 diff
(99.7 %id)
CA310992 Human Lung Epithelial cells, lung .c 4513 to 5096 602 to 19   AAA   584/584
(100 %)
4 diff
(99.4 %id)
CA942912 Pancreas, Purified pancreatic islet .c 4532 to 5121 1 to 590   tiling clone,   590/590
(100 %)
0 diff
(100 %id)
CK903057 Pancreas, Purified pancreatic islet .c 4548 to 5105 1 to 558     Submitted on the opposite strand 558/558
(100 %)
0 diff
(100 %id)
DA691469   .c 4606 to 5190 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DB124051 thymus .c 4606 to 5167 2 to 564   tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
AA836052 germinal center B cell .c 4609 to 4796 1 to 188       188/188
(100 %)
0 diff
(100 %id)
FN149596 breast carcinoma .c 4808 to 4916 106 to 1     Submitted on the opposite strand 106/106
(100 %)
4 diff
(96.3 %id)
AK021833 whole embryo, mainly head .c 4846 to 6461 1 to 1623   tiling clone, available from FLJ,   1623/1623
(100 %)
6 diff
(99.7 %id)
BX951912   .c 4855 to 5433 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
FN048136 breast carcinoma .c 5068 to 5136 1 to 69       69/70
(98 %)
1 diff
(98.6 %id)
TI_154163812   .c 5254 to 6040 70 to 846       777/1063
(73 %)
37 diff
(96.6 %id)
AK021534 whole embryo, mainly head .c 5277 to 6614 1 to 1342   available from FLJ,   1342/1342
(100 %)
3 diff
(99.8 %id)
FN119788 breast carcinoma .c 5303 to 5412 115 to 2     Submitted on the opposite strand 114/115
(99 %)
0 diff
(100 %id)
FN048620 breast carcinoma .c 5367 to 5477 111 to 1     Submitted on the opposite strand 111/111
(100 %)
0 diff
(100 %id)
BE541211 cervix .c 5546 to 6127 1 to 580       580/581
(99 %)
6 diff
(99.0 %id)
AA284564 ovarian tumor, ovary .c 5582 to 6006 14 to 438       425/438
(97 %)
6 diff
(98.7 %id)
FN051122 breast carcinoma .c 5685 to 5756 70 to 1     Submitted on the opposite strand 70/78
(89 %)
2 diff
(97.5 %id)
FN046464 breast carcinoma .c 5746 to 5845 99 to 1     Submitted on the opposite strand 99/100
(99 %)
1 diff
(99.0 %id)
FN128263 breast carcinoma .c 5806 to 5912 105 to 1     Submitted on the opposite strand 105/105
(100 %)
3 diff
(97.2 %id)
TI_149311281   .c 5813 to 6611 871 to 84   AAA   788/959
(82 %)
16 diff
(98.4 %id)
TI_154024512   .c 5897 to 6611 800 to 90   AAA   711/712
(99 %)
4 diff
(99.5 %id)
TI_154024572   .c 5907 to 6611 788 to 86   AAA   703/704
(99 %)
3 diff
(99.6 %id)
CA439663 lung, Metastatic Chondrosarcoma .c 5917 to 6611 707 to 17   AAA   691/691
(100 %)
4 diff
(99.5 %id)
BU689332 lung .c 5923 to 6611 705 to 17   AAA   689/689
(100 %)
0 diff
(100 %id)
CA439708 lung, Metastatic Chondrosarcoma .c 5927 to 6611 699 to 17   AAA   683/683
(100 %)
3 diff
(99.6 %id)
CA942674 Pancreas, Purified pancreatic islet .c 6037 to 6615 586 to 8   tiling clone,   579/586
(98 %)
0 diff
(100 %id)
AI638568 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 6190 to 6615 422 to 1       422/422
(100 %)
2 diff
(99.6 %id)
FN066228 breast carcinoma .c 6223 to 6286 1 to 64       64/65
(98 %)
1 diff
(98.5 %id)
FN151665 breast carcinoma .c 6240 to 6341 100 to 1     Submitted on the opposite strand 100/100
(100 %)
2 diff
(98.0 %id)
BU674060 lung, Primary Lung Epithelial Cells .c 6367 to 6611 1 to 245   AAA Submitted on the opposite strand 245/245
(100 %)
0 diff
(100 %id)
AA284565 ovarian tumor, ovary .c 6374 to 6611 238 to 1       238/238
(100 %)
0 diff
(100 %id)
D16886   .c 6445 to 6613 1 to 169       169/169
(100 %)
0 diff
(100 %id)
BQ917974 large cell carcinoma, lung .d 1 to 868 49 to 933 E2Y G3V N5I I6* tiling clone,   885/1017
(87 %)
43 diff
(95.8 %id)
DA303662 hippocampus .e 1 to 559 2 to 560 I85V tiling clone, capped   559/559
(100 %)
2 diff
(99.7 %id)
BQ300324 bladder_tumor .f 1 to 454 1 to 455 T3S P4T E9R F10I E11* tiling clone,   455/455
(100 %)
7 diff
(98.5 %id)
BM980995 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 147 to 888 760 to 19   tiling clone, AAA   742/742
(100 %)
1 diff
(99.9 %id)
TI_157602233   .f 249 to 879 762 to 129   AAA   634/935
(67 %)
28 diff
(97.1 %id)
TI_149273996   .f 261 to 879 702 to 84   AAA   619/832
(74 %)
1 diff
(99.9 %id)
BM968382 lung, Primary Lung Epithelial Cells .f 261 to 879 637 to 19   tiling clone, AAA   619/623
(99 %)
1 diff
(99.9 %id)
DB094173 testis .g 1 to 539 2 to 540 exact tiling clone, capped   539/539
(100 %)
0 diff
(100 %id)
BX507935   .h 1 to 748 1 to 744 exact tiling clone,   744/744
(100 %)
5 diff
(99.4 %id)
BF245422 brain, glioblastoma .i 1 to 603 6 to 597 exact tiling clone,   597/847
(70 %)
21 diff
(97.6 %id)
T83512 liver and spleen .i 3 to 371 1 to 388 exact     388/389
(99 %)
26 diff
(93.4 %id)
R05910 liver and spleen .i 3 to 237 1 to 237 exact     237/239
(99 %)
9 diff
(96.3 %id)
AA007675 liver and spleen .i 3 to 534 1 to 534 exact tiling clone,   534/535
(99 %)
8 diff
(98.6 %id)
AA011429 liver and spleen .i 3 to 319 1 to 321 exact fully sequenced,   321/321
(100 %)
3 diff
(99.1 %id)
AA011392 liver and spleen .i 289 to 607 321 to 1   fully sequenced,   321/321
(100 %)
3 diff
(99.1 %id)
R05825 liver and spleen .i 358 to 605 250 to 3   tiling clone,   248/254
(97 %)
0 diff
(100 %id)
AI817071 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .j-u 1 to 517 521 to 6   tiling clone,   516/521
(99 %)
0 diff
(100 %id)
BX479404   .j-u 28 to 492 1 to 465       465/465
(100 %)
1 diff
(99.8 %id)
BG223483 normal squamous epithelium, tongue .j-u 137 to 478 40 to 382       343/382
(89 %)
6 diff
(98.5 %id)
AA309782   .j-u 147 to 527 1 to 381   tiling clone,   381/381
(100 %)
0 diff
(100 %id)
BY995322   .j-u 248 to 911 21 to 684       664/684
(97 %)
8 diff
(98.9 %id)
CN413488 embryonic stem cells, cell lines H1, H7, andH9 .j-u 469 to 1192 1 to 724   tiling clone,   724/724
(100 %)
0 diff
(100 %id)
DA363556 subthalamic nucleus .j-u 568 to 1126 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BF351915 head_neck .j-u 603 to 915 1 to 313       313/314
(99 %)
1 diff
(99.7 %id)
DA812066 ovary, tumor tissue .j-u 682 to 938 2 to 258   capped   257/259
(99 %)
6 diff
(97.7 %id)
BQ924444 sciatic nerve .j-u 776 to 1673 1 to 904 exact     904/904
(100 %)
34 diff
(96.3 %id)
AK093765 thymus .j-u 938 to 2709 1 to 1772 exact tiling clone, available from FLJ,   1772/1772
(100 %)
0 diff
(100 %id)
DB110058 thymus .j-u 939 to 1521 2 to 585 exact capped   584/584
(100 %)
1 diff
(99.9 %id)
CA335786 anterior rhombomeres 1-4 (4 pooled) .j-u 1105 to 1310 206 to 1     Submitted on the opposite strand 206/220
(93 %)
6 diff
(97.3 %id)
CB857323 anterior tongue, pooled .j-u 1112 to 1310 24 to 222     Submitted on the opposite strand 199/222
(89 %)
6 diff
(97.3 %id)
CN371054 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j-u 1200 to 1773 9 to 582       574/582
(98 %)
6 diff
(99.0 %id)
AL708148 human skeletal muscle .j-u 1210 to 1436 1 to 227       227/230
(98 %)
1 diff
(99.6 %id)
BQ438630 bone marrow, from acute myelogenous leukemia .j-u 1330 to 2100 1 to 774       774/778
(99 %)
8 diff
(99.0 %id)
FN077643 breast carcinoma .j-u 1359 to 1435 74 to 1     Submitted on the opposite strand 74/75
(98 %)
3 diff
(96.0 %id)
BX956624   .j-u 1398 to 1733 1 to 336       336/336
(100 %)
1 diff
(99.8 %id)
CD656001 Embryonic Stem cells .j-u 1418 to 2179 49 to 800       752/824
(91 %)
6 diff
(99.3 %id)
CN371053 embryonic stem cells, cell lines H1, H7, andH9 .j-u 1448 to 2157 1 to 709       709/709
(100 %)
5 diff
(99.3 %id)
CB963124 Blood vessels - aorta, basilar and artery .j-u 1462 to 2200 1 to 746       746/763
(97 %)
18 diff
(97.7 %id)
R68419 placenta .j-u 1643 to 1981 1 to 348       348/357
(97 %)
16 diff
(95.6 %id)
R56661 placenta .j-u 1680 to 2008 1 to 336       336/336
(100 %)
10 diff
(97.1 %id)
FN084804 breast carcinoma .j-u 1801 to 1910 1 to 106       106/112
(94 %)
4 diff
(96.5 %id)
FN064611 breast carcinoma .j-u 1842 to 1953 113 to 1     Submitted on the opposite strand 113/113
(100 %)
2 diff
(98.3 %id)
AI089205 pooled .j-u 2055 to 2442 391 to 4       388/391
(99 %)
0 diff
(100 %id)
BX476259   .j-u 2084 to 2590 1 to 507       507/507
(100 %)
2 diff
(99.7 %id)
TI_149273922   .j-u 2089 to 2708 711 to 93   AAA   619/893
(69 %)
1 diff
(99.9 %id)
BM968329 lung, Primary Lung Epithelial Cells .j-u 2089 to 2708 637 to 19   AAA   619/635
(97 %)
1 diff
(99.9 %id)
AI016180   .j-u 2119 to 2442 327 to 4       324/327
(99 %)
0 diff
(100 %id)
AI301387 placenta .j-u 2134 to 2442 312 to 3       310/312
(99 %)
0 diff
(100 %id)
DB343269 thymus .j-u 2161 to 2709 550 to 1       550/550
(100 %)
1 diff
(99.9 %id)
AA460604   .j-u 2180 to 2670 1 to 490       490/490
(100 %)
1 diff
(99.8 %id)
AW043728 pooled .j-u 2192 to 2709 525 to 8       518/525
(98 %)
0 diff
(100 %id)
AI280294 placenta .j-u 2199 to 2442 246 to 3       244/246
(99 %)
0 diff
(100 %id)
BF109812 pooled .j-u 2214 to 2709 499 to 4       496/499
(99 %)
0 diff
(100 %id)
BF439464 pooled .j-u 2217 to 2707 491 to 1       491/491
(100 %)
0 diff
(100 %id)
BF887253 testis_normal .j-u 2224 to 2496 1 to 273       273/273
(100 %)
4 diff
(98.6 %id)
CD722063 eye, lacrimal gland .j-u 2237 to 2709 1 to 473   AAA   473/473
(100 %)
0 diff
(100 %id)
DB526570 testis .j-u 2253 to 2708 1 to 458     Submitted on the opposite strand 458/458
(100 %)
11 diff
(97.6 %id)
BQ002336 Chondrosarcoma, Left Pelvis .j-u 2256 to 2709 472 to 19   AAA   454/454
(100 %)
1 diff
(99.8 %id)
R68420 placenta .j-u 2466 to 2704 245 to 6       240/245
(97 %)
0 diff
(100 %id)
R56827 placenta .j-u 2501 to 2709 214 to 6       209/214
(97 %)
0 diff
(100 %id)
DB250501 uterus .k-u 1 to 582 2 to 584 R38X R40P P42S G43R A44G ... tiling clone, capped   583/583
(100 %)
1 diff
(99.9 %id)
BF759564 colon .k-u 529 to 963 16 to 461   tiling clone,   446/461
(96 %)
6 diff
(98.7 %id)
BE181775 head_neck .k-u 552 to 910 359 to 2     Submitted on the opposite strand 358/359
(99 %)
0 diff
(100 %id)
TI_149288601   .k-u 577 to 1178 783 to 180   tiling clone,   604/784
(77 %)
0 diff
(100 %id)
BM970434 lung .k-u 597 to 1178 685 to 102   tiling clone, AAA   584/667
(87 %)
0 diff
(100 %id)
BE693463 breast .l-u 1 to 327 6 to 322   tiling clone,   317/322
(98 %)
6 diff
(98.2 %id)
BE926422 breast .l-u 2 to 326 333 to 9   tiling clone,   325/333
(97 %)
0 diff
(100 %id)
BF742561 breast .l-u 116 to 327 24 to 232       209/232
(90 %)
10 diff
(95.7 %id)
BP328170 prostata .l-u 163 to 746 1 to 585 exact tiling clone,   585/585
(100 %)
1 diff
(99.9 %id)
DA406782 thalamus .m-u 1 to 567 2 to 568 exact tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
AW386852 pnet .n-u 1 to 303 353 to 51 T26S tiling clone,   303/374
(81 %)
0 diff
(100 %id)
AK299928 brain Gene CPSF6, variant not shown         Suspected internal deletion, this clone was ignored    
DC377904 brain Gene CPSF6, variant not shown         Suspected internal deletion, this clone was ignored    
TI_1948080310   Gene CPSF6, variant not shown       fully sequenced, This clone was ignored    
TI_1948080311   Gene CPSF6, variant not shown       fully sequenced, This clone was ignored    
TI_1948080476   Gene CPSF6, variant not shown       fully sequenced, This clone was ignored    
TI_1948080477   Gene CPSF6, variant not shown       fully sequenced, This clone was ignored    
TI_1948080652   Gene CPSF6, variant not shown       fully sequenced, This clone was ignored    
TI_1948080653   Gene CPSF6, variant not shown       fully sequenced, This clone was ignored    
TI_1948080828   Gene CPSF6, variant not shown       fully sequenced, This clone was ignored    
TI_1948080829   Gene CPSF6, variant not shown       fully sequenced, This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k-u, .l-u, .m-u, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI